Files and links (1)
Published, Version of Record (VoR)CC BY-NC-SA V4.0, Open
Journal article
HER2 expression as a potential marker for response to therapy targeted to the EGFR
British journal of cancer, v 94(8), pp 1144-1153
04 Apr 2006
PMID: 16622439
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
Since human epidermal growth factor receptor 2 (HER2) is known to participate with the epidermal growth factor receptor (EGFR) in mitogenic signalling, we hypothesised that HER2 overexpression might indicate responsiveness to EGFR targeted therapies. MCF7 breast cancer cells transfected with the HER2 gene were subcloned to establish a set of genetically related cell lines expressing graded levels of HER2 by immunoblot analysis. The subcloned cell lines and parental MCF7 cells were characterised by their growth characteristics, and cell by cell patterns of EGFR, HER2 and HER3 expression as well as levels of phosphorylated mitogen-activated protein kinase (MAPK) and AKT by laser scanning cytometry (LSC). Growth inhibition assays were used to characterise response to EGFR targeted therapy, and to determine the relationship between therapeutic response and levels of tyrosine kinase expression. The levels of growth inhibition of AG1478 and of the AG1478-trastuzumab combinations were correlated with levels of HER2 expression among the different cell lines. Among EGFR, HER2 and HER3, HER2 overexpression was the best single predictive marker, but combinations of two markers provided additional predictive information.
Metrics
Details
- Title
- HER2 expression as a potential marker for response to therapy targeted to the EGFR
- Creators
- D R Emlet - Laboratory of Cancer Cell Biology and Genetics, Department of Human Oncology, Drexel University College of Medicine, Allegheny General Hospital, 320 East North Avenue, Pittsburgh, PA 15212, USA.R Schwartz - Carnegie Mellon UniversityK A Brown - Drexel UniversityA A Pollice - Drexel UniversityC A Smith - Drexel UniversityS E Shackney - Drexel University
- Publication Details
- British journal of cancer, v 94(8), pp 1144-1153
- Publisher
- Nature Publishing Group
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Pediatrics
- Web of Science ID
- WOS:000236910300009
- Scopus ID
- 2-s2.0-33646133900
- Other Identifier
- 991019167941004721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Collaboration types
- Domestic collaboration
- Web of Science research areas
- Oncology